Columbia University Minority/Underserved Site NCI Community Oncology Research Program

哥伦比亚大学少数族裔/服务欠缺站点 NCI 社区肿瘤​​学研究计划

• 批准号: 10456730
• 负责人: Jennifer E. Amengual
• 金额: $ 101.61万
• 依托单位: COLUMBIA UNIVERSITY HEALTH SCIENCES
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-01 至 2025-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10456730
• 关键词: Advisory Committees; Age; Cancer Burden; Cancer Center; Cancer Control; Cancer Patient; Catchment Area; Clinical Research; Clinical Trials; Clinical Trials Network; Communities; Community Clinical Oncology Program; Community Health; Continuity of Patient Care; Enrollment; Ethnic Origin; Gender; Goals; Health Personnel; Herbert Irving Comprehensive Cancer Center; Individual; Infrastructure; Institutional Review Boards; Lead; Leadership; Medical center; Minority; Minority Groups; Minority Participation; Patients; Phase; Population; Prevention; Quality of life; Race; Research; Role; Screening for cancer; Sex Orientation; Site; Socioeconomic Status; Therapeutic Trials; Tissues; Universities; base; biobank; cancer care; cancer clinical trial; cancer prevention; cancer therapy; care delivery; design; health care disparity; improved; novel therapeutics; outreach; patient population; programs; screening; underserved community; underserved minority

PROJECT SUMMARY The Herbert Irving Comprehensive Cancer Center’s Minority/Underserved National Community Oncology Research Program at Columbia University Irving Medical Center (HICCC/CUIMC/MU-NCORP) has established a robust infrastructure that facilitates the identification, activation and participation in NCORP Research Base clinical trials. The overall goal of the HICCC/CUIMC/MU-NCORP is to provide the best in cancer care to the minority/undeserved population that surrounds our cancer center. The specific aims of our program are to 1) Provide and enhance access for our community of patients and healthcare providers to a portfolio of NCI Clinical Trials Network (NCTN/NCORP) trials, specifically in the four components of cancer control, cancer prevention and screening, cancer care delivery (CCD) research and cancer treatment (Phase I, II, III) as well as tissue acquisition; 2) Enhance the accrual of minority and underserved patients onto these trials by promoting the accessibility and availability of the trial portfolio and identifying and reducing accrual barriers to meet the needs of our community, 3) Lead, participate, and promote NCORP/NCTN research base studies across the cancer care continuum with a particular focus on studies that reduce healthcare disparities, and 4) Collaborate and contribute to the NCI NCORP-wide activities. Over the past four years, this strong infrastructure has led to many accomplishments. Our MU-NCORP portfolio consists of over 150 trials, and we have enrolled over 500 patients to Cancer Control and Prevention, Cancer Care Delivery and Therapeutic Trials. We have consistently exceeded the minimum 30% accrual target for minority and underserved patient populations. In addition, we have taken leadership roles within the research bases and lead many trials. By facilitating the enrollment and participation of minority and underserved cancer patients into high impactful clinical trials, we will achieve our ultimate goal of improving survival and quality of life of all individuals regardless of age, race, ethnicity, gender, sexual orientation or socioeconomic status.

项目摘要 赫伯特·欧文综合癌症中心的少数民族/服务不足的民族社区肿瘤学 哥伦比亚大学欧文医学中心（HICCC/CUIMC/MU-NCORP）的研究计划已建立 促进NCORP研究基础的识别，激活和参与的强大基础设施 临床试验。 HICCC/CUIMC/MU-NCORP的总体目标是为癌症护理提供最好的目的 我们的癌症中心周围的少数群体/不情愿的人口。我们计划的具体目的是1） 为我们的患者和医疗保健提供者社区提供并增强了NCI临床组合的访问权限 试验网络（NCTN/NCORP）试验，特别是在癌症控制的四个组成部分，预防癌症 以及筛查，癌症护理递送（CCD）研究和癌症治疗（I期，II，III）以及组织 获得; 2）通过促进这些试验，提高少数族裔和服务欠佳的患者的准确性 试用组合的可访问性和可用性，并识别和减少满足需求的障碍物 3）领导，参与和促进NCORP/NCTN研究基础研究 护理连续体特别关注减少医疗保健分配的研究，以及4）协作和 有助于NCI NCORP范围的活动。在过去的四年中，这种强大的基础设施导致了许多 我们的Mu-Ncorp投资组合包括150多个试验，我们已经招募了500多名患者 为了控制癌症和预防，癌症护理提供和治疗试验。我们一直超越 少数民族和服务不足的患者人群的最低准确性目标至少30％。此外，我们已经采取了 在研究基础上的领导角色并领导许多试验。通过促进入学和参与 少数民族和服务不足的癌症患者进入了高影响力的临床试验，我们将实现我们的最终目标 改善所有个人的生存和生活质量，无论年龄，种族，种族，性别，性取向如何 或社会经济地位。